Nuclear receptor function in skin health and disease: therapeutic opportunities in the orphan and adopted receptor classes
- 20 August 2016
- journal article
- review article
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 73 (20) , 3789-3800
Abstract
The skin forms a vital barrier between an organism’s external environment, providing protection from pathogens and numerous physical and chemical threats. Moreover, the intact barrier is essential to prevent water and electrolyte loss without which terrestrial life could not be maintained. Accordingly, acute disruption of the skin through physical or chemical trauma needs to be repaired timely and efficiently as sustained skin pathologies ranging from mild irritations and inflammation through to malignancy impact considerably on morbidity and mortality. The Nuclear Hormone Receptor Family of transcriptional regulators has proven to be highly valuable targets for addressing a range of pathologies, including metabolic syndrome and cancer. Indeed members of the classic endocrine sub-group, such as the glucocorticoid, retinoid, and Vitamin D receptors, represent mainstay treatment strategies for numerous inflammatory skin disorders, though side effects from prolonged use are common. Emerging evidence has now highlighted important functional roles for nuclear receptors belonging to the adopted and orphan subgroups in skin physiology and patho-physiology. This review will focus on these subgroups and explore the current evidence that suggests these nuclear receptor hold great promise as future stand-alone or complementary drug targets in treating common skin diseases and maintaining skin homeostasis.Keywords
This publication has 137 references indexed in Scilit:
- Small molecule inhibitors of RORγt: Targeting Th17 cells and other applicationsEuropean Journal of Immunology, 2012
- Structure-dependent activation of NR4A2 (Nurr1) by 1,1-bis(3′-indolyl)-1-(aromatic)methane analogs in pancreatic cancer cellsBiochemical Pharmacology, 2012
- Efficacy of Combined Peroxisome Proliferator-Activated Receptor-α Ligand and Glucocorticoid Therapy in a Murine Model of Atopic DermatitisJournal of Investigative Dermatology, 2011
- Murine atopic dermatitis responds to peroxisome proliferator-activated receptors α and β/δ (but not γ) and liver X receptor activatorsJournal of Allergy and Clinical Immunology, 2010
- Mast cells in atopic dermatitisCurrent Opinion in Immunology, 2009
- Coordination of inflammation and metabolism by PPAR and LXR nuclear receptorsCurrent Opinion in Genetics & Development, 2008
- PPARs and molecular mechanisms of transrepressionBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2007
- Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitisNature Genetics, 2006
- RORA, a large common fragile site gene, is involved in cellular stress responseOncogene, 2006
- PPARβ/δ selectively induces differentiation and inhibits cell proliferationCell Death & Differentiation, 2005